Third Arc Bio
Crysti Iarossi currently serves as the Director of Clinical Operations at Third Arc Bio since 2025, following a role in the same capacity at Scorpion Therapeutics from July 2023 to September 2024. Prior experience includes serving as Associate Director of Global Clinical Development Operations, Oncology at The Janssen Pharmaceutical Companies of Johnson & Johnson from January 2020 to July 2023, and as Associate Director of Clinical Operations at TARIS Biomedical from January 2016 to January 2020. Crysti Iarossi has also held positions as Lead CRA/Sr. CRA at Anika Therapeutics, Clinical Project Manager and Senior Clinical Research Associate at NinePoint Medical, Inc., Senior Clinical Research Associate at Candela Corporation, Clinical Research Associate at Enobia Pharma, Inc., and Clinical Research Associate/Neuroscience Department Coordinator at Aspect Medical Systems. Crysti Iarossi completed a degree at the University of New Hampshire from 2000 to 2004.
This person is not in any teams
This person is not in any offices
Third Arc Bio
Third Arc Bio is a biotech company developing multifunctional antibodies that generate immune synapses that precisely activate or inhibit T cells. The company’s drug development engine delivers superior biologics optimized to create best-in-class T cell engagement by leveraging two technologies that power a pipeline of high value therapeutics – a solid tumor synergy platform and an I&I platform that offers a novel approach to precision immune regulation at a tissue-specific level to achieve superior efficacy and safety. To learn more, visit www.thirdarcbio.com.